Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
Objectives: The prognosis for patients with unresectable biliary tract cancer is poor and existing chemotherapy is relatively ineffective. Therefore, a need exists for new, effective chemotherapeutic regimens. The aim of this study was to determine the efficacy and safety profile of gemcitabine plus...
Saved in:
Main Authors: | Thongprasert S., Napapan S., Charoentum C., Moonprakan S. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-14644410398&partnerID=40&md5=6b0ee5afa47dd836dc8315c1c7065d4b http://www.ncbi.nlm.nih.gov/pubmed/15668284 http://cmuir.cmu.ac.th/handle/6653943832/1955 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
by: S. Thongprasert, et al.
Published: (2018) -
Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
by: Chalyut Charoentum, et al.
Published: (2018) -
Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.
by: Chong, Wan Qin, et al.
Published: (2020) -
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
by: Yi J., et al.
Published: (2017) -
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
by: Jun Ho Yi, et al.
Published: (2018)